4 results
Primary Objective(s)The primary objective is to evaluate the efficacy and safety of CNTO 136 administered intravenously in subjects with active, ISN/RPS Class III and IV LN.Secondary ObjectivesThe secondary objectives are:Evaluate the…
1) To test and improve fall detection algorithms and predict the risk of falling during normal daily life. 2) To develop a feasible and effective training, that is suitable for diverse groups of elderly.
Part A: 52-week double-blind treatment phasePrimary* To investigate the efficacy of sirukumab (100 mg q2w for 12 months) as compared to placebo, each administered in addition to a 6-month prednisone treatment regimen Secondary* To assess cumulative…
· To evaluate the effect of zibotentan anddapagliflozin in combination and alone versusplacebo on UACR.